Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Tuesday, February 21, 2017 10:32:03 AM
1. Eliminated any issue of having funds for CE
2. Favorable financing terms (acceptable discount/warrants 20% higher and only 1/2 the number of equity issued.
3. MAJOR INSIDE BUYING...as member of the Board.
4. Payoff of debt with proceeds with significant operating funds remaining for CE/FDA applications
As the mantra goes: "there are many reasons for an insider to sell...but only one reason why they buy!"
#3 should tell everyone the prospects for success.
...expecting another upgrade this week.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM